Industry News
Novogen says Cantrixil trial progressing as planned
Novogen, an ASX-listed oncology drug development company, has announced that its phase I clinical trial of Cantrixil in ovarian cancer is progressing as planned. [ + ]
New regenerative tissue technology developed
Scientists have developed a new technology, tissue nano-transfection (TNT), that can generate any cell type of interest for treatment within a patient's own body. [ + ]
La Trobe University joins ASTech
The ARC Training Centre for Portable Analytical Separation Technologies (ASTech) has announced La Trobe University as the latest addition to its university nodes. [ + ]
US scientists correct heritable heart condition in human embryos
US scientists have used CRISPR to edit human embryos, removing a mutation linked to a heritable heart condition. [ + ]
Is workplace health and safety important to you?
If the answer is yes, then the SAFETYconnect conference and exhibition in Sydney is a must-attend event for you and your team. [ + ]
Misfolded pancreatic protein can induce symptoms of diabetes
US researchers have discovered that the symptoms of diabetes can be induced by a misfolded form of a pancreatic protein. [ + ]
IBM launches CTMS to streamline research operations
IBM's Clinical Trial Management System (CTMS) for Sites is designed to streamline the clinical trials management process and maximise operational efficiencies. [ + ]
Blocking the enzyme that helps tumours grow
Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to scientists from the University of Southampton. [ + ]
US Salmonella outbreak linked to microbiology laboratories
Public health officials in several US states have identified an outbreak of Salmonella Typhimurium infections linked to various clinical, commercial, and college and university teaching microbiology laboratories. [ + ]
Scitech appointed authorised distributor for 3Brain
Scitech has been appointed the authorised distributor in Australia and New Zealand for 3Brain — a Swiss-based company that sells large-scale, high-resolution microelectrode array (MEA) recording platforms for in vitro electrophysiology based on active CMOS circuits. [ + ]
Gut bacteria composition affects nutritional choices
Two new studies have revealed that the gut bacteria composition affects nutritional choices as well as reproduction, using common fruit flies as a model system. [ + ]
'DNA spellchecker' errors cause cancer
Scientists have identified important processes that create cancer-causing mutations by studying the genomes of more than 1000 tumours. [ + ]
Walter and Eliza Hall in $400m royalties deal for cancer drug
The Walter and Eliza Hall Institute of Medical Research has made a landmark deal worth up to US$325 million ($408 million) from the partial sale of royalty rights for anticancer treatment venetoclax. [ + ]
US scientists genetically modify human embryos
Scientists in the US have reportedly modified the genes of human embryos using CRISPR. [ + ]
GL Sciences partners with Xperential Scientific
GL Sciences has partnered with Xperential Scientific, a scientific instrumentation, consumable, software and diagnostic supplier based in Melbourne, for the distribution of its product range in Australia and New Zealand. [ + ]
